North Carolina State University is part of a new initiative aimed at advancing U.S. leadership in the biopharmaceutical sector. The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) will be coordinated by the University of Delaware and is supported with a five-year, $70 million grant from the U.S. Department of Commerce – and at least $129 million from a consortium of 150 companies, educational institutions, research centers, coordinating bodies, non-profits and Manufacturing Extension Partnerships across the country.
Read more